Investment Banking

MedTech M&A Trends: Why Institutional Capital is Flooding Men's Health

Men's health has emerged as one of MedTech's hottest M&A categories in 2026. From testosterone clinics to digital urology, institutional investors are deploying capital into a sector that was taboo just five years ago.

Nirji Ventures Research
8 min readApril 2026

The Destigmatisation Premium

Men's health — encompassing sexual health, hormonal optimisation, mental health, and preventive care — has undergone a remarkable destigmatisation. This cultural shift has unlocked a massive market that institutional capital is now aggressively pursuing.

Market Dynamics

Addressable Market

The global men's health market is projected to reach $32 billion by 2028, growing at 8.5% CAGR. In Asia, the market is growing at 12% — driven by rising awareness, urbanisation, and digital health adoption.

D2C Disruption

Direct-to-consumer men's health platforms (telehealth + e-pharmacy) have proven product-market fit with 30-40% gross margins and strong LTV/CAC ratios.

Clinical Validation

The maturation of clinical evidence for treatments like testosterone replacement therapy, PDE5 inhibitors, and hair loss treatments has reduced regulatory and reputational risk for investors.

Why M&A is Accelerating

Platform Consolidation

Large healthtech platforms are acquiring specialised men's health companies to expand their service offerings and capture high-value patient segments.

Vertical Integration

Companies are acquiring across the value chain — from telehealth consultation to diagnostics to pharmacy fulfilment — to control the full patient journey.

Geographic Expansion

Asian men's health platforms with proven models in one market are acquiring local players to accelerate expansion across the region.

Notable Transactions (2025-2026)

A Singapore-based men's health platform acquired competitors in Malaysia and Thailand for $45M combined
An Indian D2C wellness brand raised $80M Series C, with half earmarked for M&A in the men's health vertical
A Japanese digital health conglomerate acquired a Korean telemedicine platform specialising in sexual health for $120M

What Makes a Men's Health Company Acquirable

1. Clinical Credibility

Companies with physician-led models, clinical advisory boards, and published outcomes data command 2-3x higher valuations.

2. Subscription Revenue

Recurring revenue models with 70%+ retention rates are the primary valuation driver.

3. Data Assets

Proprietary health data — especially longitudinal patient data — creates significant strategic value for acquirers.

4. Regulatory Compliance

Companies with clean regulatory records and proactive compliance programmes reduce acquisition risk.

Strategic Implications

For Founders

If you're building in men's health, design for acquisition from day one:

Build defensible clinical credibility
Invest in subscription mechanics and retention
Ensure regulatory compliance across target markets
Accumulate proprietary health data ethically

For Investors

Men's health M&A offers attractive return profiles:

Entry valuations remain reasonable (6-10x revenue) compared to broader healthtech
Clear exit paths through strategic acquirers and platform consolidators
Growing public market comparables as more men's health companies IPO

---

Navigating this landscape requires expert guidance. Nirji Ventures offers business transformation consulting and startup consulting to help founders and executives make informed decisions.

Explore related insights:

Learn about validating market demand for complementary strategic context
Understand investment readiness to strengthen your approach
Read our guide on predictive oncology in India for deeper analysis
Read our guide on personalized medicine for deeper analysis

See how we've delivered results:

Contact our team to discuss how these insights apply to your specific situation.

Written by

Nirji Ventures Research

Research & Strategy

Nirji Ventures is a Singapore-based investment banking and strategic advisory firm with 35+ years of experience across 30+ countries. We specialise in M&A advisory, capital raising, startup consulting, and business transformation.

Put These Insights Into Action

This article is part of Nirji Ventures' commitment to helping founders, executives, and investors make better decisions. Our advisory practice turns frameworks like these into execution — whether you need startup consulting to refine your strategy, fundraising advisory to raise your next round, or go-to-market strategy consulting to drive traction.

Companies at different stages benefit from different capabilities. Growth-stage businesses often engage our investment banking practice for M&A and capital raising, while enterprises leverage our business transformation and financial advisory services. For international opportunities, explore our global expansion advisory.

See real-world results in our case studies, or continue reading in our insights library for more research and frameworks.

Frequently Asked Questions

Why is institutional capital flowing into men's health?

Destigmatisation has unlocked a $32 billion global market, D2C platforms have proven strong unit economics, and clinical validation has reduced investment risk.

What is driving M&A activity in men's health?

Platform consolidation, vertical integration across the patient journey, and geographic expansion across Asia are the three primary M&A drivers.

What makes a men's health company an attractive acquisition target?

Clinical credibility, subscription revenue with 70%+ retention, proprietary health data assets, and clean regulatory compliance records are the key factors.

Ready to Accelerate Your Growth?

Talk to Nirji Ventures about turning these insights into action for your business.

Book a Call